About us
BioBro, founded in early 2023, began its planning phase in 2018. It is dedicated to creating a platform for sharing high-quality information and facilitating professional exchanges in the biopharmaceutical field. This includes tracking the latest industry knowledge and consumables for equipment and reagents, focusing on domestic alternatives, and aiding biotechnology professionals in advancing their projects efficiently and steadily. The platform officially launched in June 2024. The team currently comprises several PhDs from Tsinghua University and master's graduates from Peking Union Medical College, bringing together experienced professionals in biopharmaceutical R&D, processes, CMC (Chemistry, Manufacturing, and Controls), and the upstream and downstream supply chain. We have already established a comprehensive solution for cell therapy, achieving domestic replacements and cost-efficiency across the entire process line. This includes key stages such as cell culture, cell sorting, cell expansion, formulation filling, connection and sealing, cell cryopreservation, and quality control release. When faced with challenges, don’t panic—BioBro is here to help!
- Website
-
www.dsxbiobro.com
External link for BioBro
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Partnership
- Founded
- 2023